Dashboard
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of 0.00% and Operating profit at 0% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at 0 times
Flat results in Sep 26
Stock is technically in a Mildly Bearish range
Risky - Negative EBITDA
Underperformed the market in the last 1 year
Stock DNA
Commodity Chemicals
INR 70 Cr (Micro Cap)
NA (Loss Making)
37
0.00%
-1.02
2.73%
-1.98
Total Returns (Price + Dividend) 
Gayatri BioOrga. for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Gayatri BioOrganics Ltd is Rated Strong Sell
Gayatri BioOrganics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 23 October 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Gayatri BioOrganics Ltd is Rated Strong Sell
Gayatri BioOrganics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 12 October 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read More
Gayatri BioOrganics Ltd is Rated Strong Sell
Gayatri BioOrganics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 September 2026, providing investors with the latest insights into the company’s performance and outlook.
Read More Announcements 
Board Meeting Outcome for Outcome Of Board Meeting Held On 05.11.2026
05-Nov-2026 | Source : BSEOutcome of Board Meeting held on 05.11.2026
Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2026
05-Nov-2026 | Source : BSEUnaudited Financial Results for the quarter and Half Year Ended
Board Meeting Intimation for Meeting To Be Held On 05.11.2026
02-Nov-2026 | Source : BSEGayatri Bioorganics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 inter alia to consider and approve 1.Un-audited Financial Results along with Limited Review Report for the Quarter and Half year ended 30.09.2026.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Non Institution
None
Held by 2 Schemes (0.08%)
Held by 1 FIIs (0.01%)
Sandeep Kumar Reddy Tikkavarapu (21.59%)
Fursa Mauritius Spv 1 (23.48%)
53.44%
Quarterly Results Snapshot (Standalone) - Sep'26 - YoY
YoY Growth in quarter ended Sep 2026 is 0.00% vs 0.00% in Sep 2025
YoY Growth in quarter ended Sep 2026 is 123.81% vs -16.67% in Sep 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 0.00% vs 0.00% in Sep 2024
Growth in half year ended Sep 2025 is -20.51% vs -25.81% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 0.00% vs 0.00% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -25.45% vs -22.22% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 0.00% vs 0.00% in Mar 2025
YoY Growth in year ended Mar 2026 is -52.05% vs -7.35% in Mar 2025